Reported Earlier, Moderna And University Of Oxford Receive UK MHRA Authorization To Begin Phase 1/2 Study Of mRNA Cancer Vaccine For Lynch Syndrome

뉴스 본문을 불러오고 있어요.

Reported Earlier, Moderna And University Of Oxford Receive UK MHRA Authorization To Begin Phase 1/2 Study Of mRNA Cancer Vaccine For Lynch Syndrome | 웨이프 WAPE

Reported Earlier, Moderna And University Of Oxford Receive UK MHRA Authorization To Begin Phase 1/2 Study Of mRNA Cancer Vaccine For Lynch Syndrome

기사 요약

관련 종목

댓글 —